Skip to content
lifestyle.celebhomes.net
Author:
Hummingbird Bioscience
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
September 30, 2026
Hummingbird Bioscience Appoints Dr. James Garner as President
September 15, 2026
Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards
July 14, 2026